In this review, we summarize the ways that MAOA helps regulate tumor immunotherapy through various types of immune cells (such as CD8+ T cells and tumor-associated macrophages), and conclude by arguing that MAOA may act as a novel immune checkpoint or immunomodulator that regulates tumor-associated immune cell metabolism, thereby influencing the efficacy and effectiveness of immunotherapy. The gene discussed is MAOA; the disease is neoplasm.